American manufacturer of health products Johnson & Johnson, following the results of the second quarter, reported a net profit growth 1.4 times compared with the same period a year earlier to $5.607 billion. Adjusted earnings, which do not take into account one-time factors, increased by 23% over the year to $2.58 per share and exceeded economists’ forecast of $2.46 per share. Revenues amounted to 20.56 billion dollars, a decrease of 1.3% over the past 12 months. In organic terms, the index increased by 3.9%. During the earnings period, the company sold medical supplies worth $3.54 billion, increasing the rate for the year by 1.2%. Pharmaceutical sales grew by 1.7% to $10.53 billion. At the same time, medical devices were sold in the amount of $6.49 billion, which is 6.9% less than in the same period last year.